Baseline Predictors and Influence of Early Weight Loss during an Intensive Weight Management Programme on Remission of Type 2 Diabetes after 12 Months—Post-Hoc Analysis of the Diabetes Remission Clinical Trial (DiRECT)

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 291-OR
Author(s):  
MICHAEL E.J. LEAN ◽  
WILMA S. LESLIE ◽  
NAVEED SATTAR ◽  
GEORGE THOM ◽  
ELIZABETH L. MCCOMBIE ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Weight Loss ◽  
Diabetes Remission ◽  
Management Programme ◽  
Post Hoc Analysis ◽  
Weight Management Programme ◽  
Post Hoc ◽  
Early Weight Loss

651-P: Higher Doses of Dulaglutide Induce Weight Loss in Patients with Type 2 Diabetes (T2D) Regardless of Baseline BMI: Post-hoc Analysis of AWARD-11

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 651-P
Author(s):  
ENZO BONORA ◽  
JUAN P. FRIAS ◽  
RALEIGH MALIK ◽  
ANITA KWAN ◽  
SOHINI RAHA ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Weight Loss ◽  
Post Hoc Analysis ◽  
Induce Weight Loss ◽  
Post Hoc ◽  
Baseline Bmi ◽  
Higher Doses

scholarly journals Effect of once‐weekly dulaglutide versus insulin glargine in people with type 2 diabetes and different baseline glycaemic patterns: A post hoc analysis of the AWARD‐2 clinical trial

2019 ◽  
Vol 21 (11) ◽  
pp. 2570-2575 ◽  
Author(s):  
Francesco Giorgino ◽  
Maria Yu ◽  
Axel Haupt ◽  
Zvonko Milicevic ◽  
Luis‐Emilio García‐Pérez
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Insulin Glargine ◽  
Post Hoc Analysis ◽  
Post Hoc
Sign in / Sign up

Export Citation Format

Share Document